1. Albino, A. P., Lloyd, K. O., Houghton, A. N., Oettgen, H. F., and Old, L. J., 1981, Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. Journal of Experimental Medicine, 154, 1764?1778.
2. Bran, A. K., and Desmarais, C. L., 1983, Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer. Journal of the National Cancer Institute, 71, 507?516.
3. Doyle, A., Martin, W. J., Funa, K., Gazdar, A., Carney, D., Martin, S. E., Linnoila, I., Cuttitta, F., Mulshine, J., Bunn, P., and Minna, J., 1985, Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. Journal of Experimental Medicine, 161, 1135?1151.
4. Eisenbach, L., Segal, S., and Feldman, M., 1983, MHC imbalance and metastatic spread in Lewis lung carcinoma. International Journal of Cancer, 32, 113?120.
5. Fidler, I. J., Gersten, D. M., and Budmen, M. B., 1976, Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity. Cancer Research, 36, 3160?3165.